C12N 9/6494
Neprilysin , i.e. enkephalinase or neutral-endopeptidase 24.11
Official title: {Neprilysin (3.4.24.11), i.e. enkephalinase or neutral-endopeptidase 24.11}
C12N9/6494 (Neprilysin , i.e. enkephalinase or neutral-endopeptidase 24.11) appears on 20 US grants and 33 published applications in this corpus.
Search patents in C12N- Granted patents
- 20
- Published applications
- 33
- Assignees
- 18
- Inventors
- 68
- Latest grant
- 13 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 2 |
| 2004 | 1 | 1 |
| 2005 | 0 | 2 |
| 2006 | 0 | 2 |
| 2007 | 0 | 0 |
| 2008 | 2 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 3 |
| 2011 | 2 | 1 |
| 2012 | 0 | 2 |
| 2013 | 1 | 1 |
| 2014 | 1 | 0 |
| 2015 | 1 | 4 |
| 2016 | 0 | 3 |
| 2017 | 1 | 1 |
| 2018 | 3 | 1 |
| 2019 | 1 | 3 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- T cell receptors and methods of use thereof13 Jan 2026US 12,522,644 B2University Health Network
- Bone delivery conjugates and method of using same to target proteins to bone15 Feb 2022US 11,248,021 B2Alexion Pharmaceuticals, Inc.
- Methods, compositions, and kits for detection of bacterial proteases31 Dec 2019US 10,520,496 B2City of Hope
- Bone delivery conjugates and method of using same to target proteins to bone19 Jun 2018US 10,000,532 B2Alexion Pharmaceuticals, Inc.
- Modulation of muscle and adipocyte distribution and fate24 Apr 2018US 9,950,043 B2The Board of Trustees of the Leland Stanford Junior University
- Pathology-responsive recombinant cells and uses thereof18 Sep 2025US 2025/0290037 A1The Regents of the University of California
- Pharmaceutical composition for treating alzheimer's disease27 Jul 2023US 2023/0233615 A1Gwo Xi Stem Cell Applied Technology Co., Ltd.
- T cell receptors and methods of use thereof2 Jun 2022US 2022/0169696 A1University Health Network
- Methods and compositions for treatment of protein aggregation-based disorders23 Dec 2021US 2021/0395716 A1Valerion Therapeutics, LLC
- Method for increasing neprilysin expression and activity17 Dec 2020US 2020/0390857 A1
Most cited
By later US patents
- Bone delivery conjugates and method of using same to target proteins to bone39US 7,763,712 B2Enobia Pharma Inc. · 2010
- Bone delivery conjugates and method of using same to target proteins to bone37US 7,960,529 B2Enobia Pharma Inc. · 2011
- Bone delivery conjugates and method of using same to target proteins to bone29US 10,000,532 B2Alexion Pharmaceuticals, Inc. · 2018
- Method and compositions for promoting osteogenesis25US 7,399,466 B2Enobia Pharma Inc. · 2008
- Composition, methods and reagents for the synthesis of a soluble form of human PHEX23US 6,790,649 B1Universite de Montreal · 2004